Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension ; volume:41 ; number:3 ; day:10 ; month:1 ; year:2024 ; pages:1062-1074 ; date:3.2024
Advances in therapy ; 41, Heft 3 (10.1.2024), 1062-1074, 3.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Barberà, Joan
Jansa, Pavel
Klings, Elizabeth
Ristić, Arsen
Keogh, Anne
Solum, Derek
Rao, Youlan
Grover, Rob
Saib, Isil
Sood, Namita
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-023-02769-7
- URN
-
urn:nbn:de:101:1-2404291048162.801393283648
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Barberà, Joan
- Jansa, Pavel
- Klings, Elizabeth
- Ristić, Arsen
- Keogh, Anne
- Solum, Derek
- Rao, Youlan
- Grover, Rob
- Saib, Isil
- Sood, Namita
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study
Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension
Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) : An Open-Label Observational Study
Arterial hypertension
Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label Extension
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
Pulmonary arterial hypertension
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents
Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study
Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study
Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension
Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) : An Open-Label Observational Study
Arterial hypertension
Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label Extension
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
Pulmonary arterial hypertension
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents
Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study
Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study
Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension
Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) : An Open-Label Observational Study
Arterial hypertension
Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label Extension
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
Pulmonary arterial hypertension
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents